169 related articles for article (PubMed ID: 22027642)
1. Sunitinib induced pyoderma gangrenosum-like ulcerations.
Akanay-Diesel S; Hoff NP; Kürle S; Haes J; Erhardt A; Häussinger D; Schulte KW; Bölke E; Matuschek C; Budach W; Gerber PA; Homey B
Eur J Med Res; 2011 Nov; 16(11):491-4. PubMed ID: 22027642
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
ten Freyhaus K; Homey B; Bieber T; Wilsmann-Theis D
Br J Dermatol; 2008 Jul; 159(1):242-3. PubMed ID: 18489600
[No Abstract] [Full Text] [Related]
3. [Sunitinib-induced pyoderma gangrenosum].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2013 Dec; 140(12):841-2. PubMed ID: 24315238
[No Abstract] [Full Text] [Related]
4. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
[No Abstract] [Full Text] [Related]
5. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
6. Sunitinib-induced pyoderma gangrenosum-like skin ulcer.
Kuntz T; Koushk-Jalali B; Kreuter A
CMAJ; 2020 May; 192(20):E552. PubMed ID: 32452467
[No Abstract] [Full Text] [Related]
7. Pyoderma Gangrenosum Associated with Sunitinib: A Case Report.
Sevimli Dikicier B
Adv Skin Wound Care; 2019 Sep; 32(9):427-429. PubMed ID: 31408027
[TBL] [Abstract][Full Text] [Related]
8. Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.
Nahm WJ; Mota JA; Rojas S; Hizon BJ; Gordon C
Am J Case Rep; 2018 Jul; 19():844-848. PubMed ID: 30022021
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma gangrenosum-like ulceration of the lower extremity secondary to sunitinib therapy: a case report.
Lopez Pineiro M; Willis E; Yao C; Chon SY
SAGE Open Med Case Rep; 2018; 6():2050313X18783048. PubMed ID: 29977559
[TBL] [Abstract][Full Text] [Related]
10. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
Yamaguchi Y; Yanagi T; Sato K; Yoshimoto N; Hirata Y; Ujiie I; Nishimura M; Natsuga K; Shiiya C; Tsukinaga I; Shimizu H
J Dermatol; 2018 Apr; 45(4):483-486. PubMed ID: 29235669
[TBL] [Abstract][Full Text] [Related]
11. Drug-Induced Pyoderma Gangrenosum: A Review.
Wang JY; French LE; Shear NH; Amiri A; Alavi A
Am J Clin Dermatol; 2018 Feb; 19(1):67-77. PubMed ID: 28624960
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum in a patient with chronic granulomatous disease: A case report.
Nanoudis S; Tsona A; Tsachouridou O; Morfesis P; Loli G; Georgiou A; Zebekakis P; Metallidis S
Medicine (Baltimore); 2017 Aug; 96(31):e7718. PubMed ID: 28767612
[TBL] [Abstract][Full Text] [Related]
13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
14. Erosive nappy erythema following sunitinib intake.
Kharmoum S; Errihani H
Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
[No Abstract] [Full Text] [Related]
15. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
Al Enazi MM; Kadry R; Mitwali H
J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
[No Abstract] [Full Text] [Related]
16. [Development of spindle cell squamous cell carcinoma within a longstanding pyoderma gangrenosum].
Drexler K; Berneburg M; Karrer S
Dermatologie (Heidelb); 2022 Nov; 73(11):880-883. PubMed ID: 35471236
[TBL] [Abstract][Full Text] [Related]
17. [Pyoderma gangrenosum: case report].
Cavka V; Situm M; Poduje S; Brtan A; Mandusić N; Cubrilović Z
Acta Med Croatica; 2012 Oct; 66 Suppl 1():25-8. PubMed ID: 23193817
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum with pulmonary involvement?
Liu ZH; Lu XL; Fu MH; Zhang GY; Liu WD
Eur J Dermatol; 2008; 18(5):583-5. PubMed ID: 18693166
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports.
Khoshnam-Rad N; Gheymati A; Jahangard-Rafsanjani Z
Anticancer Drugs; 2022 Jan; 33(1):e1-e8. PubMed ID: 34282745
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]